Adrian Sayers1, Jonathan H Tobias. 1. Academic Rheumatology, Department of Clinical Science at North Bristol, University of Bristol, Bristol BS2 8HW, United Kingdom. Jon.Tobias@bristol.ac.uk.
Abstract
CONTEXT: Relationships between vitamin D exposure of the mother in pregnancy and skeletal development of the child are poorly understood. OBJECTIVES: Our objectives were to establish whether background UVB levels in the third trimester of pregnancy are related to bone mineral content (BMC) of the child, and to examine whether these relationships are explained by effects on height, fat, or lean mass. DESIGN: This was a prospective cohort study. SETTING: The Avon Longitudinal Study of Parents and Children, a population-based birth cohort, was studied. PARTICIPANTS: A total of 6995 boys and girls with a mean age of 9.9 yr was studied. OUTCOME MEASURES: Prespecified analyses of relationships between background UVB levels in the third trimester of pregnancy, and total body less head BMC, bone area (BA), bone mineral density, and area-adjusted BMC as measured by dual-energy x-ray absorptiometry scans at 9.9 yr were performed. RESULTS: Maternal UVB exposure was positively related to BMC (g) [9.6 (5.3, 13.8)], BA (cm(2)) [8.1 (4.3, 11.9)], and bone mineral density (g/cm(-2)) [0.003 (0.001, 0.004)], but not area-adjusted BMC (g) [0.69 (-0.22, 1.56)], suggesting an effect on bone size. Both height-dependent (cm) [0.18 (0.03, 0.32)] and height-independent (cm(2)) [4.1, (2.0, 6.2)] effects contributed to this association between UVB and BA. Although maternal UVB exposure was also related to lean mass (g) [163 (89, 237)], a positive association between UVB and BA persisted after adjusting for both height and lean mass [2.8 (1.0, 4.6)]. CONCLUSIONS: Maternal UVB exposure is related to bone size at age 9.9 yr independently of height and lean mass, suggesting that vitamin D status in pregnancy exerts direct effects on periosteal bone formation in subsequent childhood.
CONTEXT: Relationships between vitamin D exposure of the mother in pregnancy and skeletal development of the child are poorly understood. OBJECTIVES: Our objectives were to establish whether background UVB levels in the third trimester of pregnancy are related to bone mineral content (BMC) of the child, and to examine whether these relationships are explained by effects on height, fat, or lean mass. DESIGN: This was a prospective cohort study. SETTING: The Avon Longitudinal Study of Parents and Children, a population-based birth cohort, was studied. PARTICIPANTS: A total of 6995 boys and girls with a mean age of 9.9 yr was studied. OUTCOME MEASURES: Prespecified analyses of relationships between background UVB levels in the third trimester of pregnancy, and total body less head BMC, bone area (BA), bone mineral density, and area-adjusted BMC as measured by dual-energy x-ray absorptiometry scans at 9.9 yr were performed. RESULTS: Maternal UVB exposure was positively related to BMC (g) [9.6 (5.3, 13.8)], BA (cm(2)) [8.1 (4.3, 11.9)], and bone mineral density (g/cm(-2)) [0.003 (0.001, 0.004)], but not area-adjusted BMC (g) [0.69 (-0.22, 1.56)], suggesting an effect on bone size. Both height-dependent (cm) [0.18 (0.03, 0.32)] and height-independent (cm(2)) [4.1, (2.0, 6.2)] effects contributed to this association between UVB and BA. Although maternal UVB exposure was also related to lean mass (g) [163 (89, 237)], a positive association between UVB and BA persisted after adjusting for both height and lean mass [2.8 (1.0, 4.6)]. CONCLUSIONS: Maternal UVB exposure is related to bone size at age 9.9 yr independently of height and lean mass, suggesting that vitamin D status in pregnancy exerts direct effects on periosteal bone formation in subsequent childhood.
Authors: S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt Journal: Lancet Date: 1993-01-09 Impact factor: 79.321
Authors: Carolyn M Fronczak; Anna E Barón; H Peter Chase; Colleen Ross; Heather L Brady; Michelle Hoffman; George S Eisenbarth; Marian Rewers; Jill M Norris Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: M K Javaid; S R Crozier; N C Harvey; C R Gale; E M Dennison; B J Boucher; N K Arden; K M Godfrey; C Cooper Journal: Lancet Date: 2006-01-07 Impact factor: 79.321
Authors: Nicholas C Harvey; Allan Sheppard; Keith M Godfrey; Cameron McLean; Emma Garratt; Georgia Ntani; Lucy Davies; Robert Murray; Hazel M Inskip; Peter D Gluckman; Mark A Hanson; Karen A Lillycrop; Cyrus Cooper Journal: J Bone Miner Res Date: 2014-03 Impact factor: 6.741
Authors: S N Karras; P Anagnostis; E Bili; D Naughton; A Petroczi; F Papadopoulou; D G Goulis Journal: Osteoporos Int Date: 2013-08-02 Impact factor: 4.507
Authors: Craig F Munns; Nick Shaw; Mairead Kiely; Bonny L Specker; Tom D Thacher; Keiichi Ozono; Toshimi Michigami; Dov Tiosano; M Zulf Mughal; Outi Mäkitie; Lorna Ramos-Abad; Leanne Ward; Linda A DiMeglio; Navoda Atapattu; Hamilton Cassinelli; Christian Braegger; John M Pettifor; Anju Seth; Hafsatu Wasagu Idris; Vijayalakshmi Bhatia; Junfen Fu; Gail Goldberg; Lars Sävendahl; Rajesh Khadgawat; Pawel Pludowski; Jane Maddock; Elina Hyppönen; Abiola Oduwole; Emma Frew; Magda Aguiar; Ted Tulchinsky; Gary Butler; Wolfgang Högler Journal: J Clin Endocrinol Metab Date: 2016-01-08 Impact factor: 5.958
Authors: Cyrus Cooper; Nicholas C Harvey; Nicholas J Bishop; Stephen Kennedy; Aris T Papageorghiou; Inez Schoenmakers; Robert Fraser; Saurabh V Gandhi; Andrew Carr; Stefania D'Angelo; Sarah R Crozier; Rebecca J Moon; Nigel K Arden; Elaine M Dennison; Keith M Godfrey; Hazel M Inskip; Ann Prentice; M Zulf Mughal; Richard Eastell; David M Reid; M Kassim Javaid Journal: Lancet Diabetes Endocrinol Date: 2016-03-02 Impact factor: 32.069